ClinicalTrials.Veeva

Menu

Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules

C

Chinese PLA General Hospital (301 Hospital)

Status

Enrolling

Conditions

Thyroid Nodule

Treatments

Procedure: ultrasound-guided thermal ablation

Study type

Observational

Funder types

Other

Identifiers

NCT06733753
2024-656

Details and patient eligibility

About

To evaluate the long-term outcomes of ultrasound-guided thermal ablation for Bethesda III/IV thyroid nodules

Full description

To evaluate and predict the long-term clinical outcomes of ultrasound-guided thermal ablation for Bethesda III/IV thyroid nodules

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. confirmation of Bethesda III or IV on fine- needle aspiration and negative on Braf V600E test
  2. no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, neck and chest CT
  3. refusal or ineligibility for surgery
  4. follow-up time ≥12 months

Exclusion criteria

  1. follicular neoplasm or malignancy findings on biopsy
  2. no suspicious of malignancy in US
  3. patients with contra-lateral vocal cord paralysis
  4. follow- up time less than 12 months

Trial design

600 participants in 1 patient group

ultrasound-guided thermal ablation
Description:
ultrasound-guided thermal ablation
Treatment:
Procedure: ultrasound-guided thermal ablation

Trial contacts and locations

2

Loading...

Central trial contact

Lin Yan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems